Pages that link to "Q53226674"
Jump to navigation
Jump to search
The following pages link to CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modification. (Q53226674):
Displaying 4 items.
- Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds (Q35859052) (← links)
- Pharmacogenomics and therapeutic prospects in Alzheimer's disease (Q36273420) (← links)
- Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease (Q37031522) (← links)
- Pharmacogenomics and therapeutic prospects in dementia (Q37111344) (← links)